Search Results 751-760 of 38628 for Liver failure

1. Generalized anxiety disorder - Diagnosis and treatment - Mayo Clinic

   ... function in your daily life. The two main treatments for ... Some herbal supplements, such as kava and valerian, increase the risk of serious liver damage.

2. Hepatitis C livers now usable for transplant into patients uninfected with hepatitis C - Mayo Clinic

   Seeking to shorten wait time to transplant for patients with end-stage liver disease, Mayo Clinic transplant hepatologists and surgeons led a multisite, ...

3. Heart Valve Surgery Clinical Trials - Mayo Clinic Research

   Increased liver stiffness often means there is chronic liver disease and fibrosis. ... failure are considered risk factors for development of liver fibrosis.

4. Terry M. Therneau, Ph.D. - Mayo Clinic Faculty Profiles

   Terry M. Therneau, Ph.D., is a Mayo Clinic statistician focused on aging and dementia, Alzheimer's disease, liver disease, and survival analysis.

5. Mayo Clinic graduate students tackle diabetes and liver disease

   Since type 2 diabetes and non-alcoholic fatty liver disease are associated with metabolism, understanding the mechanisms that drive these cellular cargo trucks ...

6. A Study to Evaluate the Effectiveness and Safety of Elafibranor for Patients with Nonalcoholic Fatty Liver Disease - Mayo Clinic

   A Study to Evaluate the Effectiveness and Safety of Elafibranor for Patients with Nonalcoholic Fatty Liver Disease ... failure. Using efficient double ...

7. Alina M. Allen, M.D., M.S. - Mayo Clinic Faculty Profiles

   The research program of Alina M. Allen, M.D., at Mayo Clinic is focused on improving outcomes for patients with nonalcoholic fatty liver disease (NAFLD).

8. Exploring the use of MRE and liver stiffness measurement to guide treatment and predict outcomes in patients with NAFLD - Mayo Clinic

   The ability to monitor disease progression in nonalcoholic fatty liver disease (NAFLD) and understand its impact on liver outcomes remains poorly understood ...

9. Cirrhosis - Doctors and departments - Mayo Clinic

   This advanced stage of liver damage ... Mayo researchers were among the first to identify nonalcoholic fatty liver disease and primary sclerosing cholangitis.

10. Foam Sclerotherapy for the Treatment of Symptomatic Kidney or Liver Cysts in Patients with Autosomal Dominant Polycystic Kidney and Liver Disease - Mayo Clinic

    ... disease (ADPKD) and autosomal dominant polycystic liver disease (ADPLD). Participation eligibility. Participant eligibility includes age, gender, type and ...